Global Coalition on Aging (GCOA) Launches Cross-Sector Alliance Committed to Health Innovation at High-Level Forum on The Silver Economy

Alliance for Health Innovation Brings Patient, Policy, Academic, Industry & Global Health Stakeholders Together to Drive Solutions that Support a Thriving Innovation Sector & Healthy Aging 

November 8, 2022 (New York, NY) – Today, the Global Coalition on Aging (GCOA), along with cross-sector stakeholders representing patient advocacy, policy, industry, and academic communities, announced the launch of the Alliance for Health Innovation at the High-Level Forum on the Silver Economy in New York. The Alliance is dedicated to establishing the importance of innovation in achieving healthy aging and health equity through investments, policy reforms, and strategic partnerships. GCOA announced the Alliance during a panel discussion at the High-Level Forum featuring patient advocacy organizations, HIV and healthcare equity organizations, biopharmaceutical companies, and more.

“GCOA is committed to bringing stakeholders from across the global health spectrum together to advance innovation that benefits all populations, which requires a broad array of partnerships and communities to confront the complex health challenges that come with population aging,” said Michael Hodin, CEO of the Global Coalition on Aging (GCOA) and convener of the Alliance for Health Innovation. “The Alliance will play a central role in advocating for policy reforms and solutions that enable the robust and thriving innovation sector to support healthy aging, advance health equity, and ensure that people can live healthier and longer lives.”

With the next decade defined by healthy aging, the Alliance is focused on advancing policies that reimagine and reshape aging in the 21st century. Policy priorities of the Alliance include:

  • Spending on Health Innovation as an Investment
  • Re-imagine 21st Century Aging and Health Needs
  • Ensure an Access Framework is Judged by Health Equity Metrics Based on Innovation
  • Emphasize the Role of Care Delivery to All Societies
  • Encourage Strong Intellectual Property Protections

“Innovation drives the development, advancement, and discovery of medical products, treatments, and technologies necessary to achieve health equity and support healthy aging,” said Sue Peschin, President and CEO of the Alliance for Aging Research, and a founding member. “The work of the Alliance for Health Innovation will ensure that health equity and healthy aging are front and center in conversations about the value of innovation to patients.”

Today, our world faces an urgent challenge – providing quality care to the rapidly growing population of older adults. The COVID-19 pandemic, like the HIV epidemic, highlight the seriousness of existing gaps in systems and programs. Government policies that enable patients to access the best care and most effective life-changing medicines are critically important in protecting against disparities related to aging and longevity,” said Rekha Ramesh, Vice President, Head of Global Policy at Gilead Sciences, Inc., a founding member of the Alliance. “At Gilead, it is our mission to deliver innovative therapies that positively impact outcomes for patients everywhere, and we are proud to join members of the Alliance in helping inform policy solutions to ensure those who need our therapies receive them in support of healthy aging.”

“To achieve healthy aging, we must improve patient access to innovative treatments for communicable diseases such as HIV which bear a disproportionate impact on historically underserved populations,” said Scott Bertani, Director of Advocacy at HealthHIV, a founding member of the Alliance. “This collaboration of cross-sector leaders will share new ideas to address equity, access, and affordability issues that persist in our healthcare system.”

The launch of the Alliance at this year’s High-Level Forum on the Silver Economy underscores the group’s recognition that aging populations can be drivers of productivity and wealth creation by remaining active, engaged, and working. The Alliance welcomes the perspective and engagement of stakeholders across the spectrum to support and advance solutions that drive innovation and better outcomes for aging populations.

About the Global Coalition on Aging

The Global Coalition on Aging (GCOA) aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. Through research, public policy analysis, advocacy and strategic communications, GCOA is advancing innovative policy and market solutions and working to ensure global aging is a path to health, productivity, and economic growth.

About the High-Level Forum on The Silver Economy

The Silver Economy Forum 2022 launches new ideas and explores unique collaborations and discoveries that impact healthy aging for older people, and everyone. SEF 2022 focuses on the policies and practices required to leverage the potential of the $17 trillion Silver Economy and the potential investment opportunities of the market.

Latest Developments

We keep our members and partners in touch with the most recent updates and opinions in the worldwide dialogue on population longevity and related issues.

GCOA Sign-on Letter to Governor Spanberger: Consequences of Importing Federal Price Caps on Virginians’ Access to Medicine & Healthy Aging Opportunities

Dear Governor Spanberger: We, the undersigned organizations, bring deep, on‑the‑ground experience serving older Americans, patients managing complex and chronic conditions, and their caregivers across Virginia and nationwide. We also have a clear understanding of which policies and programs are effective and where they fall short.

New Report Summarizes State of Expert Opinions on Japan’s Adult Vaccine Policy as Population Shifts Older

The Global Coalition on Aging (GCOA), Health and Global Policy Institute (HGPI), and the Asia-Pacific Consortium for Healthy Aging and Adult Immunization (AP-CHAAI) today announced the launch of Strengthening Vaccine Policy for Healthy Aging and Economic Growth in Japan, a landscape analysis examining the state of vaccine policy in super-aging Japan. Based on a comprehensive review of over 100 policy documents, recommendations, reports, academic papers, and gray literature articles, the report, which was funded by GSK, summarizes the latest academic research and policy discourse around adult vaccines.

WSJ Letter to the Editor: How Flu Vaccine Policies Affect the Economy

Your editorial “Vinay Prasad’s Vaccine Kill Shot” (Review & Outlook, Feb. 12) points out that a recent decision by Mr. Prasad, the leader of the Food and Drug Administration’s vaccine division, will have negative consequences. Mr. Prasad’s decision to reject Moderna’s flu vaccine without even reviewing it is even worse than you describe. Denying us a new, innovative flu vaccine is horrible health policy. Innovation is at risk because, as Moderna’s CEO has said, if the largest market is off limits, investments won’t be made. But the decision will also have economic consequences. Investment in preventive health is critical as our population ages. In its April 2025 World Economic Outlook report, the International Monetary Fund dedicated an entire chapter to the need for healthier longevity as the global population ages.

Global Coalition on Aging, Leading G7 Government Officials, Call for Incentivized Antibiotic Innovation

The Global Coalition on Aging (GCOA), in partnership with the Japanese Pharmaceutical Manufacturer’s Association (JPMA), and public health leaders call on G7 governments to fund pull incentives and make “fair share” investments in antibiotic innovation to fight the global antimicrobial resistance (AMR) crisis. GCOA, JPMA, and health and government officials from the European Union, Italy, Japan, and United Kingdom recently convened to discuss how G7 countries must respond. GCOA today published a report detailing takeaways from the closed-door meeting, “The Role of G7 Governments in Global Efforts to Encourage Antimicrobial Development Through a Pull Incentive: Challenges and Collaboration.”

2024 AMR Preparedness Index Progress Report Highlights Urgent Need For Global Action Against Antimicrobial Resistance

Today, the Global Coalition on Aging (GCOA) and the Infectious Diseases Society of America (IDSA) launched the 2024 AMR Preparedness Index Progress Report. Released in the lead up to the United Nations General Assembly 2024 High-level Meeting on Antimicrobial Resistance (AMR) this September, the 2024 Progress Report assesses how the eleven largest global economies have advanced on calls to action laid out in the 2021 AMR Preparedness Index.

New Global Analysis Across Five Cities Shows Inequities in Adult Immunization Uptake, Signaling Need to Redesign Local and National Policy Interventions

GSK, in collaboration with the Global Coalition on Aging (GCOA), announced a new report from the IQVIA Institute for Human Data Science (IQVIA Institute). The report, funded by GSK, explores the role of social and structural determinants of health in adult vaccine access and uptake across five global cities with strong data about their aging populations: Bangkok, Thailand; Brussels, Belgium; Chicago, US; Manchester, United Kingdom; and New York City, US.